Skip to content

Japt.gr

Hellenic Atherosclerosis Society
  • HOME
  • ABOUT
    • SCOPE
    • EDITORIAL BOARD
  • CURRENT ISSUE
  • ARCHIVES
    • VOLUME 13 (2022)
      • Volume 13 – Issue 3
      • Volume 13 – Issue 2
      • Volume 13 – Issue 1
      • Volume 13 – Suppl. 1
    • VOLUME 12 (2021)
      • Volume 12 – Issue 1
      • Volume 12 – Issue 2
      • Volume 12 – Issue 3
      • Volume 12 – Suppl. 1
    • VOLUME 11 (2020)
      • Volume 11 – Issue 1
      • Volume 11 – Issue 2
      • Volume 11 – Issue 3
      • Volume 11 – Suppl. 1
    • VOLUME 10 (2019)
      • Volume 10 – Issue 1
      • Volume 10 – Suppl. 1
    • VOLUME 9 (2018)
      • Volume 9 – Issue 1
      • Volume 9 – Issue 2
      • Volume 9 – Issue 3
      • Volume 9 – Issue 4
    • VOLUME 8 (2017)
      • Volume 8 – Issue 1
      • Volume 8 – Issue 2
      • Volume 8 – Issue 3
      • Volume 8 – Issue 4
    • VOLUME 7 (2016)
      • Volume 7 – Issue 1
      • Volume 7 – Issue 2
      • Volume 7 – Issue 3
      • Volume 7 – Issue 4
    • VOLUME 6 (2015)
      • Volume 6 – Issue 1
      • Volume 6 – Issue 2
      • Volume 6 – Issue 3
      • Volume 6 – Issue 4
    • VOLUME 5 (2014)
      • Volume 5 – Issue 1
      • Volume 5 – Issue 2
      • Volume 5 – Issue 3
    • VOLUME 4 (2013)
      • Volume 4 – Issue 1
      • Volume 4 – Issue 2
      • Volume 4 – Issue 3
    • VOLUME 3 (2012)
      • Volume 3 – Issue 3
  • FOR AUTHORS
  • SUBMIT MANUSCRIPT
  • CONTACT
  • Menu

Tag Archives: dyslipidemia

PCSK9 inhibitors: The breakthrough lipid-lowering treatment at real-life setting – A 2-year regional lipid clinic experience

Georgia Anastasiou, George Liamis, Haralampos Milionis, Moses Elisaf, Eliza Christopoulou, Theodora Dimitriou, Evangelos N. Liberopoulos

Pharmacological management of nonalcoholic fatty liver disease: Limitations, challenges and new therapeutic opportunities

Eleni A. Karavia, Kyriakos E. Kypreos

The role of lipid-lowering treatment in the secondary prevention of ischemic stroke

Eirini Konstantinidou, Konstantinos Tziomalos

The cardioprotective effects of flavonoids: a focus on classic cardiovascular risk factors

Eleni Kokkou, Nikoleta Bozini, Maria Lavda, Konstantinos Mourouzis, Gerasimos Siasos

Pathophysiological mechanisms of dyslipidemia in patients with nephrotic syndrome: A fresh look

M.S. Elisaf, S. Filippas-Ntekouan

Endothelial dysfunction in heart failure: The role of statins

Evangelos Oikonomou, Gerasimos Siasos, Christina Chrysohoou, Dimitris Tousoulis

Europe to US: Re-establish specific low density lipoprotein cholesterol targets because we all need them

Vasilios G. Athyros, Konstantinos Tziomalos, Asterios Karagiannis

The composite role of PCSK9 protein

E. Klouras, M. Elisaf

Effects of monotherapy with high-dose rosuvastatin compared with the combination of low-dose rosuvastatin with fenofibrate or n-3 fatty acids on non-lipid serum parameters in patients with severe mixed dyslipidemia

AP. Agouridis, TD. Filippatos, MS. Kostapanos, V. Tsimihodimos, DP. Mikhailidis, AD. Tselepis, MS. Elisaf

Inhibition of proprotein convertase subtilisin/kexin type 9 (PCSK9) A new approach to lipid lowering treatment

E. Klouras, E. Liberopoulos, M. Elisaf

Post navigation

1 2 Next »

CURRENT ISSUE

Empagliflozin in mice fed on a fast-food diet: Preliminary biochemical data
The role of epidemiology research in economic evaluation for Health Technology Assessment
Type 1 diabetes mellitus and cardiovascular risk: A short review
Health literacy in relation to health outcomes in hypertension: A systematic review
A Collection of Position Statements and Opinions on e-cigarette use and cardiovascular disease: On behalf of the Working Group on Epidemiology of the Hellenic Atherosclerosis Society

Keywords

acute coronary syndrome (4) Arterial hypertension (3) arterial stiffness (5) Atherosclerosis (19) blood pressure (3) cardiovascular disease (22) cardiovascular diseases (6) cardiovascular events (3) Cardiovascular risk (5) coronary artery disease (4) coronary heart disease (4) COVID-19 (4) diabetes (3) diabetes mellitus (9) diet (4) dyslipidemia (14) ezetimibe (4) Familial hypercholesterolemia (4) Heart failure (5) hypertension (7) inflammation (9) Ischemic stroke (3) lipoproteins (4) longevity (3) Mediterranean diet (7) metabolic syndrome (7) mortality (7) NAFLD (3) non-alcoholic fatty-liver disease (4) obesity (7) omega-3 fatty acids (3) outcome (3) PCSK9 inhibitors (4) physical activity (4) platelets (8) primary prevention (3) pulse wave velocity (3) rosuvastatin (3) smoking (3) statins (14) stroke (3) thrombosis (4) treatment (5) type 2 diabetes (3) type 2 diabetes mellitus (4)
Journal of Atherosclerosis Prevention and Treatment    ©2023
A SiteOrigin Theme